Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited)

v3.23.3
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
REVENUE:        
Product revenue, net $ 3,989 $ 3,989
COSTS AND EXPENSES:        
Cost of revenue 2,374 2,374
Research and development 21,050 22,201 69,535 57,202
Selling, general and administrative 8,712 7,390 23,131 22,161
Costs and Expenses 32,136 29,591 95,040 79,363
Operating loss (28,147) (29,591) (91,051) (79,363)
Interest income, net 172 610 1,715 825
Net loss (27,975) (28,981) (89,336) (78,538)
Preferred stock deemed dividend 4,255
Net loss available to common stockholders $ (27,975) $ (28,981) $ (89,336) $ (82,793)
Net loss per common share, basic $ (1.83) $ (4.24) $ (7.40) $ (18.58)
Net loss per common share, diluted $ (1.83) $ (4.24) $ (7.40) $ (18.58)
Weighted average common shares outstanding, basic 15,327,558 6,843,099 12,079,583 4,455,943
Weighted average common shares outstanding, diluted 15,327,558 6,843,099 12,079,583 4,455,943